Skip to main content
Show full summary

Lord Balfe to ask Her Majesty's Government how they intend to cooperate with the European Medicines Agency's Pharmacovigilance Risk Assessment Committee from 1 January 2021; whether this cooperation will include (1) participating in the Committee's reviews, and (2) accepting the Committee's findings; and if so, what level of participation in the decision making process they foresee.  HL8364

Question HL8364: tabled on 22 September 2020 and due for answer by 6 October 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government how they intend to cooperate with the European Medicines Agency's Pharmacovigilance Risk Assessment Committee from 1 January 2021; whether this cooperation will include (1) participating in the Committee's reviews, and (2) accepting the Committee's findings; and if so, what level of participation in the decision making process they foresee.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.